PLGI yields 0.02% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 8
Combined, PLGI + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PLGI + PFE for your $10,000?
PLGI allocates across equities, fixed income, and options within a single portfolio to pursue both growth and income over time. The fund primarily invests in a focused set of individual stocks, predominantly US-listed issuers, while retaining flexibility to adjust exposure using bonds, preferred securities, ETFs, and cash equivalents. Equity holdings may span growth-oriented and income-producing companies, complemented by allocations to corporate and government bonds across varying maturities and credit qualities. To support income generation and manage volatility, the fund employs covered call writing on equity positions and may sell cash-secured put options. Portfolio allocations across equities, fixed income, and cash are actively adjusted within defined ranges based on market conditions and security-level analysis. The strategy integrates fundamental, quantitative, and options-based decision-making, with the potential for higher portfolio turnover as positions are actively managed.
Full PLGI Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.